Edward H. Kerns
Pharmaceutical Science · 2003–2014
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmaceutical Science — 8 citations into it
- Pediatrics, Perinatology and Child Health — 5 citations into it
Whom Edward H. Kerns trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Edward H. Kerns overall
Papers from Edward H. Kerns's perspective
Ordered by how strongly the researchers Edward H. Kerns trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug penetration in solid tumours (Nature Reviews. Cancer)
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. (Molecular Pharmaceutics)
- Rational use of in vitro P-glycoprotein assays in drug discovery. (Journal of Pharmacology and Experimental Therapeutics)
- Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. (Journal of Pharmacy and Science)
- Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System (Pharmaceutical Research)
- CALCULATING LOG POCT FROM STRUCTURES
- Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs (Nature reviews. Drug discovery)
- Absorption classification of oral drugs based on molecular surface properties.
- The superfamily of organic anion transporting polypeptides. (Biochimica et Biophysica Acta)
Their papers
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery (2010) — 822 citations
- Synthesis and Structure−Activity Relationship Studies of N‐Benzyl-2- phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer (2014)
- Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization (2008) — 834 citations
- High throughput artificial membrane permeability assay for blood-brain barrier. (2003) — 968 citations